ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Epinephrine Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2025-11-07 · last update 2025-11-07

Manufacturers: Hospira, Inc., a Pfizer Company

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Epinephrine, Injection, .1 mg/1 mL (NDC 0409-4933-01)Hospira, Inc., a Pfizer CompanyTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 11/07/2025
Updated 11/07/2025
Discontinued 11/07/2025
Epinephrine, Injection, .1 mg/1 mL (NDC 0409-4933-10)Hospira, Inc., a Pfizer CompanyTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 11/07/2025
Updated 11/07/2025
Discontinued 11/07/2025

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)